Drug‑Induced Syncope from Diltiazem–Sildenafil Interaction

Mechanistic Contributors

• Combined vasodilatory and negative‑chronotropic effects of diltiazem (calcium‑channel blocker) and sildenafil (PDE‑5 inhibitor) can produce marked hypotension and bradycardia, precipitating syncope. – European Society of Cardiology 1
• Diltiazem depresses sinus‑node activity and atrioventricular (AV) conduction, leading to bradycardia that may render cardiac output insufficient to maintain cerebral perfusion. – European Society of Cardiology 1
• Diltiazem alone is a recognized cause of symptomatic orthostatic hypotension, a frequent mechanism of drug‑related syncope. – European Society of Cardiology 2
• Citalopram can prolong the QT interval and is listed among psychotropic agents that may trigger torsade de pointes, especially in women. – European Society of Cardiology 1, 3
• Antidepressants, including citalopram, are acknowledged contributors to drug‑induced orthostatic hypotension. – European Society of Cardiology & American Heart Association 2, 4
• The coexistence of QT‑interval prolongation (from citalopram) with diltiazem‑induced bradycardia heightens the risk of malignant arrhythmias. – European Society of Cardiology 1

Diagnostic Evaluation

• A 12‑lead electrocardiogram should be obtained to identify bradycardia (< 50 bpm), AV‑conduction delays, and QTc prolongation (> 450 ms in men, > 470 ms in women). – European Society of Cardiology 1
• Orthostatic vital‑sign measurements are required; a systolic drop ≥ 20 mmHg or diastolic drop ≥ 10 mmHg on standing confirms orthostatic hypotension. – European Society of Cardiology 5
• Lack of compensatory tachycardia when changing posture suggests drug‑induced autonomic impairment. – European Society of Cardiology & American Heart Association 5, 3
• If the initial ECG shows borderline bradycardia (50–60 bpm) or first‑degree AV block, 24–48 h Holter monitoring is recommended to detect intermittent high‑grade AV block. – European Society of Cardiology 1

Immediate Management

• Discontinue or reduce the diltiazem dose; calcium‑channel blockers are among the most common precipitants of drug‑related syncope. – American College of Cardiology 6
• Consider switching citalopram to an antidepressant with a lower propensity for QT prolongation when QTc is abnormal. – European Society of Cardiology 1, 3
• For confirmed orthostatic hypotension, increase dietary sodium (≈ 8–10 g/day) and fluid intake (≈ 2–3 L/day) unless contraindicated by heart‑failure or renal disease. – American College of Cardiology 6
• Educate patients on positional strategies: rise slowly from supine to sitting to standing, avoid prolonged standing, and cross legs when symptomatic. – European Society of Cardiology & American College of Cardiology 2, 6
• If non‑pharmacologic measures fail, a low‑dose fludrocortisone regimen (0.1–0.2 mg daily) may be trialed with careful monitoring for electrolyte disturbance. – American College of Cardiology 6

Polypharmacy and Risk Assessment

• Polypharmacy, especially in older adults, markedly increases the risk of drug‑related syncope through cumulative hypotensive effects and drug‑drug interactions. – American College of Cardiology & American Heart Association 6, 4
• Medications such as lansoprazole and finasteride are unlikely to contribute to syncope but should be reviewed for ongoing necessity. – American College of Cardiology 6
• Glycopyrrolate may cause tachycardia but is not a typical cause of syncope unless it leads to severe dehydration. – European Society of Cardiology 2

Common Pitfalls to Avoid

• Do not default to a vasovagal diagnosis; drug‑induced syncope accounts for a substantial proportion of emergency‑department presentations and should be actively considered. – (no citation needed, excluded)
• Neurological investigations are only warranted when focal neurological deficits, seizure activity, or head trauma are present, as primary neurological causes of syncope are rare. – American Heart Association 4
• After medication adjustments, confirm orthostatic stability for at least 48–72 hours before re‑introducing any vasodilating agent. – American College of Cardiology 6

Follow‑Up and Long‑Term Considerations

• When the offending agent is withdrawn, drug‑related syncope has an excellent prognosis, with most patients remaining syncope‑free at one‑year follow‑up. – (no citation, excluded)
• If diltiazem remains essential for rate control or hypertension, alternative agents with minimal bradycardic effect (e.g., amlodipine for hypertension or digoxin for rate control without AV‑block risk) should be considered. – American College of Cardiology 6

Etiology and Evaluation of Syncope

Introduction to Syncope

• Syncope results from transient global cerebral hypoperfusion and can be categorized into three major groups: neurally-mediated (reflex) syncope, orthostatic hypotension, and cardiac syncope—with cardiac causes carrying the highest mortality risk and requiring urgent evaluation 7, 8

Major Categories of Syncope

• The European Society of Cardiology recommends that vasovagal syncope, the most common form of neurally-mediated syncope, is characterized by inappropriate vasodilation and bradycardia triggered by emotional stress, fear, pain, blood phobia, or prolonged standing 9
• Carotid sinus syncope occurs when mechanical manipulation of the carotid sinuses triggers the vasovagal reflex, more commonly affecting older adults 7, 9
• Situational syncope is associated with specific triggers, including cough or sneeze, gastrointestinal stimulation, micturition, post-exercise, and post-prandial 7, 8, 9

Orthostatic Hypotension

• Classic orthostatic hypotension is defined as a sustained reduction of systolic BP ≥20 mmHg or diastolic BP ≥10 mmHg within 3 minutes of standing 9
• Primary autonomic failure syndromes, such as pure autonomic failure, multiple system atrophy, and Parkinson's disease with autonomic failure, can cause orthostatic hypotension 7, 8
• Drug-induced orthostatic hypotension can result from various medications, including tricyclic antidepressants, nitrates, and antiparkinsonian medications 10, 11

Cardiac Syncope

• Cardiac arrhythmias, such as sinus node dysfunction and atrioventricular conduction system disease, represent the most common cardiac cause of syncope 7, 8, 9
• Structural cardiac or cardiopulmonary disease, including cardiac valvular disease and obstructive cardiomyopathy, can also cause syncope 7, 8, 9

Neurological Causes

• Neurological causes of syncope, such as cerebrovascular disease and seizure disorders, are rare and should only be pursued if suggested by history or physical examination 10, 11, 12

Age-Related Patterns

• Elderly patients have a higher frequency of cardiac causes of syncope, including obstructions to cardiac output and arrhythmias from underlying heart disease 9, 11
• Orthostatic hypotension causes syncope in 6% to 33% of elderly patients, and carotid sinus hypersensitivity accounts for 30% of unexplained syncope in the elderly 11

Prognostic Implications

• Cardiac syncope carries significantly higher mortality risk, with annual mortality rates of 18-33% compared to 0-12% for non-cardiac causes 9

Common Pitfalls

• Avoid unnecessary neurological testing in the absence of head trauma or evident neurological signs, as these have low diagnostic yield 12, 10, 11
• Recognize that cardiac causes of syncope can be accompanied by upward gaze deviation, asynchronous myoclonic jerks, and brief automatisms from global cerebral hypoperfusion—these are not indications for neurological evaluation 12, 10, 11